146 results
8-K
EX-4.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
, commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee
8-K
EX-4.1
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
8-K
EX-10.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of any … adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non
424B4
APVO
Aptevo Therapeutics Inc
12 Apr 24
Prospectus supplement with pricing info
5:23pm
by the interested stockholder) those shares owned (1) by persons who are directors and also officers and (2) employee stock plans in which employee
8-K
EX-99.1
yxg4gv222et
5 Mar 24
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
8:15am
8-K
EX-99.1
7rx77a7jr3l1305h1h9w
14 Nov 23
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
12:00am
8-K
EX-4.4
09hur5 4jy8
9 Nov 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-4.2
5cjq9 ibaunokgu
9 Nov 23
Entry into a Material Definitive Agreement
5:17pm